Life Biosciences is dedicated to developing novel therapies to extend healthy human lifespan by targeting the biological causes of aging. Founded in 2017 and headquartered in Boston, MA, we are pursuing therapies targeting three molecular pathways that regulate the biology of aging: mitochondrial uncoupling, chaperone-mediated autophagy, and epigenetic reprogramming. Our platform approach enables us to develop medicines with the potential to prevent, treat, and/or reverse multiple aging-related diseases, each with critical
unmet needs.
unmet needs.
Location: United States
Employees: 11-50
Total raised: $80M
Founded date: 2017
Investors 9
Funding Rounds 1
| Date | Series | Amount | Investors |
| 08.04.2026 | Series D | $80M | - |
Mentions in press and media 22
| Date | Title | Description |
| 25.08.2026 | Индустрия долголетия привлекла миллиарды — теперь ее разработки проверяют на людях | Стартапы в сфере долголетия привлекли миллиарды долларов на разработки, призванные замедлить связанные со старением процессы. В ближайшие 12−18 месяцев несколько компаний планируют начать первые испытания на людях или представить ранние кли... |
| 19.08.2026 | Kimi Shinu Episode Seven: Why Orphanage Works Like Real Child Soldier Programs | By Henry Baker Published: Aug 19 2026, 10:54 AM EDT Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 06.07.2026 | Doctor Who Faces Its Most Uncertain Future as BBC Competitive Tender Begins | By William Chan Published: Jul 06 2026, 1:00 PM EDT Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 16.05.2026 | Учёные начинают возвращать клетки человека в «молодое» состояние | По словам одного из ведущих учёных, начать можно с восстановления зрения, а затем перейти к внутренним органам. Даже мозг может от этого выиграть. В голливудском блокбастере «Загадочная история Бенджамина Баттона», действие которого происхо... |
| 08.04.2026 | Life Biosciences Raises $80M in Series D Funding | Life Biosciences, Inc., a Boston, MA-based biotechnology company developing cellular rejuvenation therapies, raised $80M in Series D funding. Backers were not disclosed. The company intends to use the funds to support its operations into th... |
| 08.04.2026 | Top Startup and Tech Funding News – April 8 2025 | It’s Wednesday, April 8, 2026, and we’re back with today’s top startup and tech funding news. Today’s rounds highlight a clear shift toward AI infrastructure, robotics, biotech innovation, and financial platforms scaling across global marke... |
| 20.04.2023 | Humans can't live forever, but we haven't even come close to the limit for how long our bodies could last | Millions of dollars are going toward companies worldwide looking to lengthen the human lifespan. invincible_bulldog / Getty Images Redeem now Researchers estimate that the human body may not be capable of living more than 150 years. But doz... |
| 10.03.2023 | Tweekly. Выпуск 160. Бессмертие как сервис | Что сейчас растёт и как это применить 1. Бессмертие как сервис (IaaS). То, чего все хотят и боятся одновременно. 2. Цифровые клоны городов и производств — быстрая проверка «капиталоемких» гипотез. Следующий шаг - проверка жизнеспособности п... |
| 25.10.2022 | Want To Live Longer? How Life Extension Industry Will Reboot Health, Wellness and The Economy | Do you want to live a better, healthier and longer life? Me too. |
| 01.07.2021 | Life Biosciences : Appoints Seasoned Biopharma Executive Jerry McLaughlin as CEO | BOSTON, July 1, 2021 /PRNewswire/ -- Life Biosciences, a pioneering life sciences company targeting the biology of aging, today announced that the Company's Board of Directors has appointed Jerry McLaughlin as Chief Executive Officer and a ... |
Show more